T immunodepletion of the graft in allogeneic bone marrow grafts. Efficacy in the prevention of graft-versus-host reaction
Cahn, J.Y.; Hervé, P.; Flesch, M.; Plouvier, E.; Racadot, E.; Montcuquet, P.; Noir, A.; Peters, A.; Leconte des Floris, R.
Presse Medicale 15(25): 1204
1986
ISSN/ISBN: 0755-4982 PMID: 2942936 Document Number: 282877
Document emailed within 1 workday
Related Documents
Jeannet, M.; Vaucher, A.; Gervasoni, C. 1972: Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation Schweizerische Medizinische Wochenschrift 102(44): 1598-1600de Witte, T.; Janssen, J.; de Pauw, B.; Holdrinet, R.; Wessels, J.; Haanen, C. 1986: Prevention of graft-vs-host disease following allogeneic bone marrow transplantation Nederlands Tijdschrift Voor Geneeskunde 130(28): 1290-1291
Lenz, M.; Haen, M. 1991: Pneumatosis cystoides intestinalis. a possible complication of acute intestinal graft versus host reaction following allogeneic bone marrow transplantation Rontgenpraxis; Zeitschrift für Radiologische Technik 44(11): 336-338
Cooper, M.H.; Markus, P.M.; Cai, X.; Starzl, T.E.; Fung, J.J. 1991: Prolonged prevention of acute graft-versus-host disease after allogeneic bone marrow transplantation by donor pretreatment using FK 506 Transplantation Proceedings 23(6): 3238-3239
Haanen, C.; De Witte, T.; Plas, A.; Schattemberg, T. 1991: Prevention of graft-versus-host disease by lymphocyte depletion of the bone marrow graft with use of counterflow centrifugation Haematologica 76 Suppl. 1: 22-28
Blazar, B.R.; Taylor, P.A.; Fitzsimmons, W.E.; Vallera, D.A. 1994: FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation Journal of Immunology 153(4): 1836-1846
Rochant, H.; Mannoni, P.; Brun, B.; Beaujean, F.; Kritvitzki, A.; Duval, J.; Dreyfus, B. 1975: Post-hepatitic aplasia treated by grafts of allogenic bone marrow. Remission for more than 2 years. Persistance of a total hematopoietic chimera. Graft versus host reaction La Nouvelle Presse Medicale 4(16): 1183-1188
Sullivan, K.M.; Siadak, M.F.; Witherspoon, R.P. 1990: Cyclosporine treatment of chronic graft-versus-host disease following allogeneic bone marrow transplantation Transplantation Proceedings 22(3): 1336-1338
Oluwole, S.F.; Engelstad, K.; Hardy, M.A. 1992: Kinetics of prevention of graft-versus-host disease and bone marrow rejection by ultraviolet B modulation of bone marrow inoculum Transplantation Proceedings 24(6): 2858-2859
Chowdhury, N.C.; Jin, M.X.; Hardy, M.A.; Oluwole, S.F. 1993: Prevention of graft-versus-host disease after bone marrow and small bowel transplantation by ultraviolet B modulation of bone marrow cells Transplantation Proceedings 25(1 Pt 1): 475-476
Brok, H.P.; Heidt, P.J.; van der Meide, P.H.; Zurcher, C.; Vossen, J.M. 1993: Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice Journal of Immunology 151(11): 6451-6459
Tong, J.; Viale, M.; Bacigalupo, A.; Podestà, M.; Sogno, G.; Tedone, E.; Marmont, A.M. 1992: Cytokine serum levels and acute graft versus host disease after allogeneic bone marrow transplantation Haematologica 77(4): 365-366
Jansen, J.; Goselink, H.M.; Veenhof, W.F.; Zwaan, F.E.; Blotkamp, C. 1983: The impact of the composition of the bone marrow graft on engraftment and graft-versus-host disease Experimental Hematology 11(10): 967-973
Lachance, S.; Le Gouvello, S.; Roudot, F.; Kuentz, M.; Bernaudin, F.; Beaujean, F.; Bierling, P.; Cordonnier, C.; Farcet, J.P.; Vernant, J.P. 1997: Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies Transplantation 64(8): 1147-1152
Smyth, L.A.; Witt, C.S.; Christiansen, F.T.; Herrmann, R.P.; Hollingsworth, P.N.; Townend, D.C.; Edward, E.; Dawkins, R.L. 1993: The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation Bone Marrow Transplantation 12(4): 351-355
Nevo, S.; Enger, C.; Swan, V.; Wojno, K.J.; Fuller, A.K.; Altomonte, V.; Braine, H.G.; Noga, S.J.; Vogelsang, G.B. 1999: Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival Transplantation 67(5): 681-689
Lacour, J.P.; Adrien, A.; Gratecos, N.; Pesce, A.; Dujardin, P.; Ortonne, J.P. 1988: Bullous pemphigoid following graft-versus-host reaction after bone marrow allograft Presse Medicale 17(26): 1367-1368
Champlin, R.; Jansen, J.; Ho, W.; Gajewski, J.; Nimer, S.; Lee, K.; Territo, M.; Winston, D.; Tricot, G.; Reichert, T. 1991: Retention of graft-versus-leukemia using selective depletion of CD8-positive T lymphocytes for prevention of graft-versus-host disease following bone marrow transplantation for chronic myelogenous leukemia Transplantation Proceedings 23(1 Pt 2): 1695-1696
Bykova, T.A.; Kozlov, A.V.; Stancheva, N.V.; Semënova, E.V.; Kulagina, I.I.; Bondarenko, S.N.; Vavilov, V.N.; Morozova, E.V.; Zubarovskaia, L.S.; Afanas'ev, B.V. 2013: Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation Terapevticheskii Arkhiv 85(8): 60-68
Mrsić, M.; Labar, B.; Bogdanić, V.; Nemet, D.; Pavletić, Z.; Plavsić, F.; Dobrić, I.; Kastelan, A.; Marusić, M.; Zupancić-Salek, S. 1989: Combination of cyclosporine and methotrexate for prophylaxis of acute graft versus host disease after allogeneic bone marrow transplantation for leukaemias Bone Marrow Transplantation 4(Suppl): 95-96